Arrowhead Pharmaceuticals Files 8-K
Ticker: ARWR · Form: 8-K · Filed: Mar 19, 2025 · CIK: 879407
Sentiment: neutral
Topics: 8-K, corporate-governance, financial-reporting
Related Tickers: ARWR
TL;DR
Arrowhead Pharma filed an 8-K on 3/19 detailing shareholder votes and financials as of 3/12.
AI Summary
Arrowhead Pharmaceuticals, Inc. filed an 8-K on March 19, 2025, reporting on matters submitted to a vote of security holders and financial statements as of March 12, 2025. The filing includes information related to their business operations and financial condition.
Why It Matters
This filing provides an update on corporate governance and financial reporting for Arrowhead Pharmaceuticals, Inc., which is important for investors to understand the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing of corporate and financial information, not indicating any immediate operational or financial distress.
Key Players & Entities
- Arrowhead Pharmaceuticals, Inc. (company) — Registrant
- 177 E. Colorado Blvd , Suite 700 , Pasadena , CA 91105 (location) — Principal executive offices address
- 001-38042 (company) — Commission File Number
- 46-0408024 (company) — IRS Employer Identification No.
- 20250319 (date) — Filing Date
- 20250312 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the submission of matters to a vote of security holders and to provide financial statements and exhibits as of March 12, 2025.
When was Arrowhead Pharmaceuticals, Inc. incorporated?
Arrowhead Pharmaceuticals, Inc. was incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive office is located at 177 E. Colorado Blvd, Suite 700, Pasadena, CA 91105.
What is the Commission File Number for Arrowhead Pharmaceuticals, Inc.?
The Commission File Number for Arrowhead Pharmaceuticals, Inc. is 001-38042.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding ARROWHEAD PHARMACEUTICALS, INC. (ARWR).